Skip to main content
GeneralHomeInvestorsNewsUzedy

MedinCell’s partner Teva today announced refiling for approval of mdc-IRM and confirmed planned launch in the U.S. in H1 2023

By November 3, 2022March 15th, 2024No Comments1 min read